Journal of Neurology

Article	Citations
Impact of COVID-19 lockdown on sleep quality in university students and administration staff	385
Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms	256
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases	238
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)	186
Stroke in patients with SARS-CoV-2 infection: case series	169
A systematic review of neurological symptoms and complications of COVID-19	160
COVID-19-associated acute disseminated encephalomyelitis (ADEM)	151
Guillain-Barré syndrome following COVID-19: new infection, old complication?	140
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients	138
Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex	117
Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis	106
COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?	100
The advances of post-stroke depression: 2021 update	99
Acute transverse myelitis after COVID-19 pneumonia	97
Neurological and cognitive sequelae of Covid-19: a four month follow-up	93
First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease	89
Neurological manifestations associated with COVID-19: a review and a call for action	88
Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study	85
Rituximab for the treatment of multiple sclerosis: a review	78
Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19	78
Neurological involvement of coronavirus disease 2019: a systematic review	75
COVID-19 mRNA vaccination leading to CNS inflammation: a case series	73
Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy	71
Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials	70
A review of seizures and epilepsy following traumatic brain injury	69

Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient	68
Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine	68
Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment	68
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study	66
Bell’s palsy following COVID-19 vaccination	66
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region	63
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2	63
Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature	62
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera	61
New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review	60
Treatment of MOG antibody associated disorders: results of an international survey	60
Impact of the COVID-19 outbreak on acute stroke care	59
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients	58
Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation	56
Association of CNS demyelination and COVID-19 infection: an updated systematic review	56
Digital therapeutics in neurology	56
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up	55
Etiologic distribution of dizziness and vertigo in a referral-based dizziness clinic in South Korea	54
COVID-19 in teriflunomide-treated patients with multiple sclerosis	53
The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study	52
Miller–Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19)	51
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine	51
Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review	50
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19	50
Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms	50
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential	49
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung	49
Managing disorders of consciousness: the role of electroencephalography	46
Nusinersen treatment significantly improves hand grip strength, hand motor function and MRC sum scores in adult patients with spinal muscular atrophy types 3 and 4	45
Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature	45
Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature	45
An atlas on risk factors for multiple sclerosis: a Mendelian randomization study	45
A review of pathophysiology and neuropsychiatric manifestations of COVID-19	45
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?	45
Update on benign paroxysmal positional vertigo	44
Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19	44
Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster?	44
Burden of disease in myasthenia gravis: taking the patient’s perspective	44
Levodopa challenge test: indications, protocol, and guide	44
Neurofilaments in progressive multiple sclerosis: a systematic review	43
Why do SARS-CoV-2 NSPs rush to the ER?	43
COVID-19: dealing with a potential risk factor for chronic neurological disorders	43
Clinical and pathological features in adult-onset NIID patients with cortical enhancement	43
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives	43
Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis	42
Neurological comorbidity and severity of COVID-19	42
Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection	41
Ischemic stroke associated with COVID-19: a systematic review and meta-analysis	41
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus	41
Diagnosing vestibular hypofunction: an update	40

Bickerstaff encephalitis after COVID-19	39
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis	38
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers	38
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis	38
Post-infectious Guillain–Barré syndrome related to SARS-CoV-2 infection: a case report	38
Transverse myelitis related to COVID-19 infection	38
Alzheimer’s disease clinical trial update 2019–2021	38
Cell-based assays for the detection of MOG antibodies: a comparative study	38
Primary or secondary chronic functional dizziness: does it make a difference? A DizzyReg study in 356 patients	38
Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses	37
Wearable sensors can reliably quantify gait alterations associated with disability in people with progressive multiple sclerosis in a clinical setting	37
Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome	37
Bilateral vestibulopathy: beyond imbalance and oscillopsia	37
Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study	37
The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis	37
Seizures in Alzheimer’s disease are highly recurrent and associated with a poor disease course	36
Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions	36
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients	36
Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocyto	36
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management	36
CNS penetration of potential anti-COVID-19 drugs	36
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy	35
Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysis	35
Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices	34
Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19	34
Neurological updates: neurological complications of CAR-T therapy	34
Are some patient-perceived migraine triggers simply early manifestations of the attack?	34
COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF	34
Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review	34
Central retina changes in Parkinson’s disease: a systematic review and meta-analysis	33
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223	32
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice	32
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion	32
Telerehabilitation in response to constrained physical distance: an opportunity to rethink neurorehabilitative routines	32
Risk factors for benign paroxysmal positional vertigo recurrence: a systematic review and meta-analysis	32
COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis	31
A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications	31
Hearing loss versus vestibular loss as contributors to cognitive dysfunction	31
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature	31
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod	31
Wearables in the home-based assessment of abnormal movements in Parkinson’s disease: a systematic review of the literature	30
Vestibular evoked myogenic potentials in vestibular migraine and Menière’s disease: cVEMPs make the difference	30
Frontal encephalopathy related to hyperinflammation in COVID-19	30
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment	30
SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature	30
The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients	30
Fall prediction in neurological gait disorders: differential contributions from clinical assessment, gait analysis, and daily-life mobility monitoring	29
Progression of sleep disturbances in Parkinson’s disease: a 5-year longitudinal study	29
Enlarged perivascular spaces in multiple sclerosis on magnetic resonance imaging: a systematic review and meta-analysis	29
Multifocal laminar cortical brain lesions: a consistent MRI finding in neuro-COVID-19 patients	29
COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2	29
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project	29
Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)	29
Update cerebellum and cognition	28
What has caused the fall in stroke admissions during the COVID-19 pandemic?	28
Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy	28
Acute vestibular syndrome: is skew deviation a central sign?	28
The changing landscape of optic neuritis: a narrative review	28
Emerging themes in idiopathic intracranial hypertension	28
Central positional nystagmus: an update	28
Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data	27
Pre-procedural predictive factors of symptomatic intracranial hemorrhage after thrombectomy in stroke	27
Modern machine-learning can support diagnostic differentiation of central and peripheral acute vestibular disorders	27
Outcome after surgical treatment of cerebrospinal fluid leaks in spontaneous intracranial hypotension—a matter of time	27
Mild traumatic brain injury recovery: a growth curve modelling analysis over 2 years	27
Transcranial direct current stimulation for post-stroke dysphagia: a systematic review and meta-analysis of randomized controlled trials	27
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy	27
Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis	27
Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study	26
Neurological manifestations of COVID-19: a review of what we know so far	26
Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience	26
Neuroimmune disorders in COVID-19	26
Amyotrophic lateral sclerosis patients’ and caregivers' distress and loneliness during COVID-19 lockdown	26
Ultrasonography for the diagnosis of carpal tunnel syndrome: an umbrella review	26
Repetitive transcranial magnetic stimulation for post-stroke depression: a randomised trial with neurophysiological insight	26
Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder	26
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic	26
Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience	26
Consciously processing balance leads to distorted perceptions of instability in older adults	25
The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?	25

An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention	25
Vestibular rehabilitation in Europe: a survey of clinical and research practice	25
Histopathology and high-resolution ultrasound imaging for peripheral nerve (injuries)	25
Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease	25
Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis	25
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome	25
Monkeypox virus from neurological complications to neuroinvasive properties: current status and future perspectives	25
Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence?	25
Functional motor phenotypes: to lump or to split?	25
Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder	25
Neurological update: COVID-19	24
Heritable and non-heritable uncommon causes of stroke	24
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications	24
Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature	24
Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19)	24
Myocardial infarction, stroke and cardiovascular mortality among migraine patients: a systematic review and meta-analysis	24
Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders	24
Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy	24
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential di	24
GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis	24
Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review	24
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression	24
The natural history of primary progressive aphasia: beyond aphasia	24
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review	23
Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson’s disease patients	23
Covid-19 and Parkinson’s disease: an overview	23
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value	23
Biallelic RFC1-expansion in a French multicentric sporadic ataxia cohort	23
Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group	23
A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials	23
Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis	23
Risk of acute brain lesions in dizzy patients presenting to the emergency room: who needs imaging and who does not?	23
Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2	23
Glymphatic system dysfunction in patients with juvenile myoclonic epilepsy	23
A rise in cases of nitrous oxide abuse: neurological complications and biological findings	23
Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection	23
Nanoparticles for drug delivery in Parkinson’s disease	22
Pathological neural networks and artificial neural networks in ALS: diagnostic classification based on pathognomonic neuroimaging features	22
Influence of heavy metals in Parkinson’s disease: an overview	22
Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19	22
Neurological manifestations in 404 COVID-19 patients in Washington State	22
RETRACTED ARTICLE: Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient	22
RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy	22
Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report	22
Capturing vertigo in the emergency room: three tools to double the rate of diagnosis	22
Manifold learning for amyotrophic lateral sclerosis functional loss assessment	22
Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study	22
Neurological features in SARS-CoV-2-infected patients with smell and taste disorder	22
Most degenerative cervical myelopathy remains undiagnosed, particularly amongst the elderly: modelling the prevalence of degenerative cervical myelopathy in the United Kingdom	21
Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2	21
Neurological complications of COVID-19: a preliminary review	21
A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis	21
Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap	21
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review	21
Does prior administration of rtPA influence acute ischemic stroke clot composition? Findings from the analysis of clots retrieved with mechanical thrombectomy from the RESTORE registry	21
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population	21
Axonal degeneration in Guillain–Barré syndrome: a reappraisal	21
Prevention of recurrent benign paroxysmal positional vertigo with vitamin D supplementation: a meta-analysis	21
A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection	21
Neurological update: use of cardiac troponin in patients with stroke	21
Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent	21
Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature	21
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis	21
The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes	21
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)	21
A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis	20
Palilalia as a prominent feature of anti-NMDA receptor encephalitis in a woman with COVID-19	20
Cognitive impairment in temporal lobe epilepsy: contributions of lesion, localization and lateralization	20
Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis	20
Outcomes of a 5-week individualised MDT outpatient (day-patient) treatment programme for functional neurological symptom disorder (FNSD)	20
Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients	20
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease	20
Features of intracranial hemorrhage in cerebral venous thrombosis	20
Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy	20
Cerebrovascular manifestations in hematological diseases: an update	20
Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019	20
Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term data	20
COVID-19 in Parkinson’s disease: what holds the key?	20
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis	20
STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa	20
Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis	20
Clinical, oculographic and vestibular test characteristics of Ménière’s disease	20
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C	20
Neurologic complications of Down syndrome: a systematic review	20
The sleep and circadian problems of Huntington’s disease: when, why and their importance	20
Long-term cognitive impairments following COVID-19: a possible impact of hypoxia	19
Expansion of the dimensions in the current management of acute ischemic stroke	19
Surgical techniques and functional evaluation for vestibular lesions in the mouse: unilateral labyrinthectomy (UL) and unilateral vestibular neurectomy (UVN)	19
A systematic review and meta-analysis of voxel-based morphometric studies of migraine	19
The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease	19
The “hype” of hydrops in classifying vestibular disorders: a narrative review	19
Respiratory function during enzyme replacement therapy in late-onset Pompe disease: longitudinal course, prognostic factors, and the impact of time from diagnosis to treatment start	19
Changes in the EEG spectral power during dual-task walking with aging and Parkinson’s disease: initial findings using Event-Related Spectral Perturbation analysis	19
Neurological update: cognitive rehabilitation in multiple sclerosis	19
Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study	19